CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT)

CUSIP: 218352102

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
-3,533,129
Put/Call ratio
329%
SEC-reported price per share
$20.31
Number of holders
241
Value change
-$86,283,839
Number of buys
131
Open additional details 1 more signal available
Number of sells
92
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
107,380,163

Security key

218352102

Report period

Q4 2022

Institutions

241

Top holders

10

Ownership snapshot

Top reported holders of CORT - CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F Highest disclosed value: $415,037,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $415.04M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $415.04M
VANGUARD GROUP INC $264.92M
RENAISSANCE TECHNOLOGIES LLC $184.54M
INGALLS & SNYDER LLC $178.23M
FEDERATED HERMES, INC. $142.32M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$415,037,000
16,187,049 shares
— 30 Sep 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$264,915,000
10,332,077 shares
— 30 Sep 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$184,543,000
7,197,471 shares
— 30 Sep 2022
INGALLS & SNYDER LLC
13F
Company
13F
—
denominator unverified
$178,226,000
6,951,077 shares
— 30 Sep 2022
FEDERATED HERMES, INC.
13F
Company
13F
—
denominator unverified
$142,323,000
5,550,800 shares
— 30 Sep 2022
Parallel Advisors, LLC
13F
Company
13F
—
denominator unverified
$96,649,000
3,769,455 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
241
Shares
83,493,481
Rows available
241
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
225
Q4 2022 holders
241
Holder diff
16
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .